Cargando…
A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
Significant strides have been made in the management of patients living with myeloma. However, patients with multiply relapsed or refractory multiple myeloma (MM) have a shorter overall survival; therefore, new treatments with novel mechanisms of action are needed in this patient population. Patient...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342926/ https://www.ncbi.nlm.nih.gov/pubmed/35937467 http://dx.doi.org/10.6004/jadpro.2022.13.5.13 |